Claims that HIV has been permanently eradicated from people living with the virus are false. More research, refined delivery ...
Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.
Landmark study on HIV antibodies b12 and bNAbs, their challenges, and regional effectiveness, emphasizing global HIV research ...
Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...
Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...
The ongoing monkeypox virus clade IIb outbreak in Sierra Leone has caused over 4800 confirmed cases in the first half of 2025, 5% of which are in children.1 Although the infection in most patients is ...
Decades into the battle against HIV-1, scientists are increasingly focused on a remarkable class of infection-fighting ...
The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...
This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...
Introduction The development of effective vaccines targeting human papillomavirus (HPV) has significantly contributed to disease prevention, highly relevant in immunosuppressed patients who have ...
SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results